# Clinical Assessment, Neuroimaging and Immunomarkers in Chagas Disease Study (CLINICS)

Study · id `cardio:ct-nct01650792` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01650792](<https://clinicaltrials.gov/study/NCT01650792>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01650792

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Heart failure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 500 participants.

## Technical summary

Registry record NCT01650792. Randomized; single masking; primary purpose treatment. Start 2012-07 (actual); primary completion 2024-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 500 participants (planned count; ClinicalTrials.gov record NCT01650792, source copy `cardio:ctgov-nct01650792-2023-03-03`, retrieved 2026-10-26)
- Started: 2012-07 (actual) (ClinicalTrials.gov record NCT01650792, source copy `cardio:ctgov-nct01650792-2023-03-03`, retrieved 2026-10-26)
- Primary completion: 2024-06 (anticipated) (ClinicalTrials.gov record NCT01650792, source copy `cardio:ctgov-nct01650792-2023-03-03`, retrieved 2026-10-26)
- Completion: 2024-06 (anticipated) (ClinicalTrials.gov record NCT01650792, source copy `cardio:ctgov-nct01650792-2023-03-03`, retrieved 2026-10-26)
- Countries: Brazil (ClinicalTrials.gov record NCT01650792, source copy `cardio:ctgov-nct01650792-2023-03-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01650792-2023-03-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: Clinical Assessment, Neuroimaging and Immunomarkers in Chagas Disease Study (CLINICS)
- Acronym: CLINICS
- Condition: Chagas Disease With Heart Failure
- Intervention (Drug): Aspirin
- Lead sponsor: Federal University of Bahia
- Lead sponsor class: OTHER
- Collaborator: National Institutes of Health (NIH)
- Collaborator class: NIH
- Collaborator: National Institute of Neurological Disorders and Stroke (NINDS)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Aspirin (`core:aspirin`)
- Registry lists this organization as a collaborator: National Institutes of Health (`cardio:nih`)
- Registry lists this organization as a collaborator: National Institute of Neurological Disorders and Stroke (`cardio:ninds`)

## Provenance

Content hash: 6fda4154a68f00cfb87cd79f3415cd71c8dd23b4570f8d8bd923c3c60e2d48bb
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
